Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity.
Studies in skeletal muscle demonstrate that elevation of plasma FFAs increases the sphingolipid ceramide. We aimed to determine the impact of FFA oversupply on total sphingolipid profiles in a skeletal muscle model. C2C12 myotubes were treated with palmitate (PAL). Lipidomics analysis revealed pleiotropic effects of PAL on cell sphingolipids not limited to ceramides. (13)C labeling demonstrated that PAL activated several branches of sphingolipid synthesis by distinct mechanisms. Intriguingly, PAL increased sphingosine-1-phosphate independently of de novo synthesis. Quantitative real-time PCR demonstrated that PAL increased sphingosine kinase 1 (SK1) mRNA by approximately 4-fold. This was accompanied by a 2.3-fold increase in sphingosine kinase enzyme activity. This upregulation did not occur upon treatment with oleate, suggesting some level of specificity for PAL. These findings were recapitulated in the diet-induced obesity mouse model, in which high-fat feeding increased SK1 message in skeletal muscle over 2.3-fold. These data suggest that the impact of elevated FFA on sphingolipids reaches beyond ceramides and de novo sphingolipid synthesis. Moreover, these findings identify PAL as a novel regulatory stimulus for SK1.
Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
Wei
W
Hu
Jacek
J
Bielawski
Fahumiya
F
Samad
Alfred H
AH
Merrill
L Ashley
LA
Cowart
D000818:Animals; D002460:Cell Line; D002518:Ceramides / Q000096:biosynthesis; D004032:Diet; D004789:Enzyme Activation / Q000187:drug effects; D006801:Humans; D007553:Isotope Labeling; D008246:Lysophospholipids / Q000737:chemistry / Q000378:metabolism*; D051379:Mice; D018485:Muscle Fibers, Skeletal / Q000187:drug effects* / Q000378:metabolism*; D009765:Obesity / Q000209:etiology / Q000378:metabolism; D019301:Oleic Acid / Q000494:pharmacology; D010168:Palmitates / Q000494:pharmacology*; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000235:genetics* / Q000378:metabolism*; D051381:Rats; D051102:Serine C-Palmitoyltransferase / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000096:biosynthesis / Q000737:chemistry / Q000378:metabolism; D013379:Substrate Specificity; D015854:Up-Regulation / Q000187:drug effects*; D000099157:Sphingosine Kinase
D002518:Ceramides; D008246:Lysophospholipids; D019301:Oleic Acid; D010168:Palmitates; D017853:Phosphotransferases (Alcohol Group Acceptor); D051102:Serine C-Palmitoyltransferase; D013110:Sphingosine; D000099157:Sphingosine Kinase; C060506:sphingosine 1-phosphate; C005682:safingol